Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus

Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity

(2015) H. Enocsson et al.   JOURNAL OF RHEUMATOLOGY

Extracellular, but not intracellular HMGB1, facilitates self-DNA induced macrophage activation via promoting DNA accumulation in endosomes and contributes to the pathogenesis of lupus nephritis

(2015) Xiaoyun Li et al.   MOLECULAR IMMUNOLOGY

Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register

(2015) Anna Ighe et al.   ARTHRITIS RESEARCH & THERAPY

High Mobility Group Box 1 Protein Is Methylated and Transported to Cytoplasm in Clear Cell Renal Cell Carcinoma

(2014) Fei Wu et al.   Asian Pacific Journal of Cancer Prevention

The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE

(2014) David S. Pisetsky   AUTOIMMUNITY

Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity

(2014) Ayako Hayashi et al.   Modern Rheumatology

Unknown

(2014) Fleur Schaper et al.   MOLECULAR MEDICINE

High-Mobility Group Box 1 Inhibition Alleviates Lupus-Like Disease in BXSB Mice

(2014) C. Zhang et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Anti-high mobility group box 1 (anti-HMGB1) antibodies are not related to the occurrence of cutaneous lesions in systemic lupus erythematosus

(2014) G Tan et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved

(2014) Ole Petter Rekvig et al.   Seminars in Immunopathology

Autoantibody Induction by DNA-Containing Immune Complexes Requires HMGB1 with the TLR2/MicroRNA-155 Pathway

(2013) Z. Wen et al.   JOURNAL OF IMMUNOLOGY

Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus

(2013) Helena Enocsson et al.   Translational Research

Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register

(2013) Martina Frodlund et al.   BMJ Open

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype

(2012) Hiromasa Takaishi et al.   JOURNAL OF GASTROENTEROLOGY

Unknown

(2012) Huan Yang et al.   MOLECULAR MEDICINE

Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis

(2012) Agneta Zickert et al.   ARTHRITIS RESEARCH & THERAPY

Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock

(2011) Stéphanie Barnay-Verdier et al.   INTENSIVE CARE MEDICINE

Production of recombinant human HMGB1 and anti-HMGB1 rabbit serum

(2011) Qing Lin et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Unknown

(2011) Hanna Schierbeck et al.   MOLECULAR MEDICINE

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus

(2011) Deena A Abdulahad et al.   ARTHRITIS RESEARCH & THERAPY

Expression of High Mobility Group Box Chromosomal Protein 1 and Its Modulating Effects on Downstream Cytokines in Systemic Lupus Erythematosus

(2010) J. LI et al.   JOURNAL OF RHEUMATOLOGY

The role of defective clearance of apoptotic cells in systemic autoimmunity

(2010) Luis E. Muñoz et al.   Nature Reviews Rheumatology

Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus

(2010) Chun-yan Ma et al.   RHEUMATOLOGY INTERNATIONAL

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

(2009) Daniel J. Wallace et al.   ARTHRITIS AND RHEUMATISM

Nuclear functions of the HMG proteins

(2009) Raymond Reeves   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

(2009) Nora Kostova et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

High-Mobility Group Box-1 Protein and Keratin-18, Circulating Serum Proteins Informative of Acetaminophen-Induced Necrosis and Apoptosis In Vivo

(2009) Daniel J. Antoine et al.   TOXICOLOGICAL SCIENCES

Autoantibody prevalence and lupus characteristics in a unique African American population

(2008) Diane L. Kamen et al.   ARTHRITIS AND RHEUMATISM

Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein

(2008) Hirotaka Kazama et al.   IMMUNITY

Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE

(2008) Vilma Urbonaviciute et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Systemic Lupus Erythematosus

(2008) Anisur Rahman et al.   NEW ENGLAND JOURNAL OF MEDICINE